Molecular imaging of atherosclerosis using a technetium-99m-labeled endothelin derivative

Journal of Nuclear Medicine

Volumn 39, Issue 10, 1998, Pages 1819-1822

  Dinkelborg, Ludger M ^a   Duda, Stephan H ^b   Hanke, Hartmut ^b   Tepe, Gunnar ^b   Hilger, Christoph S ^b   Semmler, Wolfhard ^b  

^a BAYER PHARMA AG   (Germany)

^b NONE

Author keywords

Balloon angioplasty; Neointimal formation; Radiopharmaceuticals; Restenosis; Technetium 99m ZK 167054

Indexed keywords

ENDOTHELIN; TECHNETIUM 99M;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; AUTORADIOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; IMMUNOHISTOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESTENOSIS; WHOLE BODY SCINTISCANNING;

ANGIOGRAPHY, DIGITAL SUBTRACTION; ANIMALS; AORTA, ABDOMINAL; AORTIC DISEASES; ARTERIOSCLEROSIS; AUTORADIOGRAPHY; FEASIBILITY STUDIES; MALE; ORGANOTECHNETIUM COMPOUNDS; RABBITS; RADIOPHARMACEUTICALS;

EID: 0031713318     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
2. Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsch KR. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res 1990;67:651-659.
3. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors. Trends pharmacol Sci 1992;13:103-108.
4. Takuwa Y, Kasuya Y, Takuwa N, et al. Endothelin receptor is coupled to phospholipase C via a pertussis toxin-insensitive guanine nucleotide-binding regulatory protein in vascular smooth muscle cells. J Clin Invest 1990;85:653-658.
5. Dinkelborg LM, Duda S, Hanke H, Tepe G, Hilger CS, Semmler W. Characterization of a technetium-99m-endothelin derivative for imaging of atherosclerosis in a rabbit balloon denudation model. J Nucl Med 1997;38(suppl):173P.
6. Doherty AM, Cody WL, DePue PL, et al. Structure-activity relationships of C-terminal endothelin hexapeptide antagonists. J Med Chem 1993;36:2585-2594.
7. 99Tc-labelled endothelin derivative. Appl Radiat Isot 1997;48:1045-1050.
8. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994;46:325-415.
9. Goto K, Warner TD. Molecular pharmacology. Endothelin versatility. Nature 1995; 375:539-540.
10. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991;325:997-1001.
11. Tahara A, Kohno M, Yanagi S, et al. Circulating immunoreactive endothelin in patients undergoing percutaneous transluminal coronary angioplasty. Metabolism 1991;40:1235-1237.
12. Zeiher AM, Goebel H, Schachinger V, Ihling C. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 1995;91:941-947.
13. Hirata Y, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989;78:225-228.
14. Bobik A, Grooms A, Millar JA, Mitchell A, Grinpukel S. Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol 1990;258:C408-C415.
15. Wang X, Douglas SA, Louden C, Vickery Clark LM, Feuerstein GZ, Ohlstein EH. Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat. Circ Res 1996;78:322-328.
16. Douglas SA, Louden C, Vickery Clark LM, et al. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. Circ Res 1994;75: 190-197.
17. Winkles JA, Alberts GF, Brogi E, Libby P. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun 1993;191:1081-1088.
18. Kowala MC, Rose PM, Stein PD, et al. Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol. Am J Pathol 1995;146:819-826.
19. Ihling C, Gobel HR, Lippoldt A, et al. Endothelin-1-like immunoreactivity in human atherosclerotic coronary tissue: a detailed analysis of the cellular distribution of endothelin-1. J Pathol 1996;179:303-308.
20. Dashwood MR, Sykes RM, Muddle JR, et al. Autoradiographic localization of [1251]endothelin binding sites in human blood vessels and coronary tissue: functional correlates. J Cardiovasc Pharmacol 1991;17(suppl 7):S458-S462.